Genomtec S.A. (WSE:GMT)

Genomtec Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	14.24	0.95	6.7	4.17	4.14	1.38
Cash & Short-Term Investments	14.24	0.95	6.7	4.17	4.14	1.38
Cash Growth	44.23%	-85.89%	60.64%	0.73%	199.28%	-81.06%
Accounts Receivable	0.83	0.06	0	0	0	0.16
Other Receivables	-	1.05	0.88	1.97	0.68	0.45
Receivables	0.83	2	1.73	2.43	0.69	0.61
Inventory	-	-	-	-	0.11	0.2
Prepaid Expenses	-	0.16	0.07	0.05	0.06	0.06
Total Current Assets	16.13	3.1	8.49	6.65	4.99	2.25
Property, Plant & Equipment	1.43	0.86	2.61	1.75	2.19	1.91
Long-Term Investments	-	7.86	-	-	-	-
Other Intangible Assets	3.49	-	0	0.03	4.55	0.03
Long-Term Deferred Charges	-	-	5.91	7.52	-	-
Other Long-Term Assets	0	0.03	0.03	0.03	0.03	0.03
Total Assets	21.08	11.86	17.04	15.97	11.76	4.22

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.22	0.76	0.78	0.94	0.9	0.59
Accrued Expenses	-	0.16	0.25	0.21	0.15	0.22
Current Portion of Long-Term Debt	-	0.44	0.42	0.39	0.37	0.25
Current Portion of Leases	0.93	0.46	0.94	0.49	0.56	0.65
Current Income Taxes Payable	-	0.12	0.14	0.12	0.06	0.15
Current Unearned Revenue	1.14	-	2.84	0.91	0.1	0.62
Other Current Liabilities	0.7	0.11	0.12	0.09	0.18	0.09
Total Current Liabilities	3.99	2.05	5.48	3.14	2.32	2.57
Long-Term Leases	0.26	0.36	1.38	1.11	1.36	0.86
Long-Term Unearned Revenue	1.05	-	2.39	3.3	3.1	0.06
Long-Term Deferred Tax Liabilities	0.04	0.01	0.06	0.04	0.06	0.01
Other Long-Term Liabilities	0.07	0.02	0.13	0.08	0.03	0.01
Total Liabilities	5.41	2.43	9.44	7.67	6.87	3.49

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.71	1.51	1.33	1.23	0.94	0.82
Additional Paid-In Capital	20.88	10.35	43.37	32.97	16.86	9.75
Retained Earnings	-22.63	-18.16	-51.31	-40.1	-31.09	-19.16
Comprehensive Income & Other	15.72	15.72	14.2	14.2	18.18	9.31
Shareholders' Equity	15.67	9.42	7.6	8.3	4.89	0.72
Total Liabilities & Equity	21.08	11.86	17.04	15.97	11.76	4.22

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.19	1.26	2.74	1.99	2.29	1.75
Net Cash (Debt)	13.06	-0.31	3.96	2.18	1.85	-0.36
Net Cash Growth	73.81%	-	81.61%	17.83%	-	-
Net Cash Per Share	-	-0.02	0.30	0.18	0.20	-0.04
Filing Date Shares Outstanding	-	15.06	14.87	12.26	10.16	8.16
Total Common Shares Outstanding	-	15.06	13.32	12.26	9.36	8.16
Working Capital	12.14	1.05	3.01	3.5	2.66	-0.31
Book Value Per Share	-	0.63	0.57	0.68	0.52	0.09
Tangible Book Value	12.18	9.42	7.6	8.27	0.33	0.7
Tangible Book Value Per Share	-	0.63	0.57	0.67	0.04	0.09
Buildings	-	2.33	2.29	2.15	1.93	0.96
Machinery	-	0.12	3.34	1.94	1.91	1.78

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error